10x Genomics and PharosAI Launch Consortium to Build Multimodal Cancer Dataset

Reuters
02/04
<a href="https://laohu8.com/S/TXG">10x Genomics</a> and PharosAI Launch Consortium to Build Multimodal Cancer Dataset

10x Genomics Inc. has announced a partnership with PharosAI, a research consortium comprising King’s College London, Queen Mary University of London, Guy’s and St Thomas’ NHS Foundation Trust, and Barts Health NHS Trust. The collaboration will utilize 10x Genomics’ Xenium spatial platform to build one of the world’s largest and most comprehensive multimodal cancer datasets. Supported by £18.9 million from the UK Government’s Research Ventures Catalyst and additional industry and charity funding, the initiative aims to accelerate cancer diagnosis, enable precision therapies, and advance new treatment discoveries through AI-ready datasets and analytical tools.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 10x Genomics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA78184) on February 04, 2026, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10